Skip to content

QUMEA AG

Switzerland CH-MF-000044306 Last updated 21 Oct 2026

Devices
1
Registries
EUDAMED
FDA recalls
0

Catalogue1

Authorised representatives

About

QUMEA makes it clear what is hidden in everyday care. Motion data becomes clear, clinically relevant insights in real time. Without invasion of privacy. This creates orientation in complex situations. Nurses not only know what is happening, but also what could happen.

Translated from the manufacturer's own website. Source

What QUMEA AG makes

QuMEA AG develops wearable motion-sensing devices, such as Mobility Sense, designed to monitor patient movement and activity in real-time for clinical assessment. These tools generate data-driven insights to support care decisions without requiring direct patient contact or invasive monitoring.

The company’s products fall under EU Class I medical devices and are registered in the EUDAMED database. QuMEA AG is headquartered in Switzerland.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What types of medical devices does QuMEA AG manufacture?

QuMEA AG specializes in wearable motion-sensing devices, such as Mobility Sense. These devices monitor patient movement and activity in real time to provide clinically relevant insights for care teams. The technology focuses on non-invasive, privacy-preserving monitoring to assist in assessing patient mobility and potential risks without direct contact.

Where is QuMEA AG based, and where are its devices listed?

QuMEA AG is headquartered in Switzerland. Its devices are registered in the EUDAMED database, which is the European Union’s medical device registry. This listing ensures transparency and compliance with EU regulatory requirements for medical devices.

How are QuMEA AG’s devices classified under EU regulations?

QuMEA AG’s devices are classified as EU Class I medical devices. This classification is determined based on the risk associated with the device’s intended use and design. Class I devices are generally considered low-risk, but they still require compliance with EU regulations to ensure safety and performance.

What kind of data do QuMEA AG’s devices provide, and how is it used?

QuMEA AG’s devices collect motion and activity data from patients in real time. This data is processed to generate clinically relevant insights, such as mobility patterns or potential changes in patient condition. The goal is to support care teams in making informed decisions without relying on invasive monitoring or direct patient interaction.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
Switzerland
Address
3, Westbahnhofstrasse, Solothurn, Switzerland
Website
www.qumea.com
Phone
+41325256050
PRRC contact
Jonas Reber
EUDAMED SRN
CH-MF-000044306